- 全部任务
- BT0307-Effect of Unilateral Injection of Botulinum Toxin on Lower Facial Asymmetry As Evaluated Using Three-Dimensional Laser Scanning
- BT0423-Effectiveness and Safety of Botulinum Toxin Type A Injection for Scar Prevention- A Systematic Review and Meta-analysis
- BT0422-International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) – part II- wrinkles on the middle and lower face, neck and chest
- BT0421-International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) – part I- upper facial wrinkles
- BT0419-Neurologic uses of botulinum neurotoxin type A
- BT0415-Effect of a Facial Muscle Exercise Device on Facial Rejuvenation
- BT0414-New Uses of AbobotulinumtoxinA in Aesthetics
- BT0413-The Practical Use of AbobotulinumtoxinA in Aesthetics
- BT0411-Effect of the Refrigerator Storage Time on the Potency of Botox for Human Extensor Digitorum Brevis Muscle Paralysis
- BT0410-BOTOX Broadening the Horizon of Dentistry
- BT0409-Enhancing Facial Esthetics by Other Modalities
- BT0407-Quantitative Magnetic Resonance Imaging Volumetry of Facial Muscles in Healthy Patients with Facial Palsy
- BT0406-Agitation predicts response of depression to botulinum toxin treatment in a randomized controlled trial
- BT0405-The functional role of the periphery in emotional language comprehension
- BT0403-Neutralizing antibodies to botulinum neurotoxin type A in aesthetic medicine five case reports
- BT0402-Botulinum toxin type A for the management of glabellar rhytids
- BT0400-An interview with Mario Polo_talking about BOTOX
- BT0399-IncobotulinumtoxinA in aesthetics russian multidisciplinary expert consensus recommendations
- BT0397-Efficacy and Safety of a New Botulinum Toxin Type A Free of Complexing Proteins
- BT0396-Balanced Botox Chemodenervation of the Upper Face Symmetry in Motion
- BT0391-A new treatment for focal dystonias incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins
- BT0390-OnabotulinumtoxinA and AbobotulinumtoxinA Dose Conversion A Systematic Literature Review
- BT0389-An Evaluation of Use of Botulinum Toxin Type A in the Management of Dynamic Forehead Wrinkles - A Clinical Study
- BT0388-Comparison and Overview of Currently Available Neurotoxins
- BT0387-Duration of Action of AbobotulinumtoxinA and OnabotulinumtoxinA A Randomized,Double-blind Study Using a Contralateral Frontalis Model
- BT0384-Technical Considerations for Filler and Neuromodulator Refinements
- BT0383-Incongruence Between Observers’ and Observed Facial Muscle Activation Reduces Recognition of Emotional Facial Expressions From Video Stimuli Tanja
- BT0381-Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines
- BT0380-Treating glabellar lines with botulinum toxin type A-hemagglutinin complex A review of the science, the clinical data, and patient satisfaction
- BT0378-Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines a randomized, double-blind study
- BT0377-Botulinum toxin type A treatment to the upper face retrospective analysis of daily practice
- BT0375-Triple-Blind, Prospective, Internally Controlled Comparative Study Between AbobotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Facial Rhytids
- BT0374-Botulinum Toxins for Facial Lines A Concise Review
- BT0373-How the Experience of Emotion is Modulated by Facial Feedback
- BT0372-A comparative assessment of three formulations of botulinum toxin A for facial rhytides a systematic review and meta-analyses
- BT0371-Immunogenicity of botulinum toxins
- BT0370-Consensus on Current Injectable Treatment Strategies in the Asian Face
- BT0368-Noninvasive Facial Rejuvenation. Part 2 Physician- Directed—Neuromodulators and Fillers
- BT0366-Consensus Recommendations for Treatment Strategies in Indians Using Botulinum Toxin and Hyaluronic Acid Fillers
- BT0364-Hyperhidrosis Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum Toxins
- BT0362-AbobotulinumtoxinA A 25-Year History
- BT0356-A Single-blind, Split-face, Randomized, Pilot Study Comparing the Effects of Intradermal and Intramuscular Injection of Two Commercially Available Botulinum Toxin A Formulas
- BT0346-Pharmacological differences and clinical implications of various botulinum toxin preparations a critical appraisal
- BT0343-Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics Onset and Duration
- BT0340-Pregnancy outcomes following exposure to onabotulinumtoxinA (1)
- BT0339-A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis
- BT0338-Botulinum Toxin Injection for Facial Wrinkles
- BT0334-Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles
- BT0333-Comparison of neurotoxic potency between a novel chinbotulinumtoxina with onabotulinumtoxina, incobotulinumtoxina and lanbotulinumtoxina in rats
- BT0332-Botox in Facial aesthetics
- BT0330-Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products (1)
- BT0329-Content of Botulinum Neurotoxin in Botox® Vistabel®, Dysport® Azzalure®, and Xeomin® Bocouture®
- BT0324-OnabotulinumtoxinA (Botox) in the Treatment of Crow’s Feet Lines in Japanese Subjects
- BT0312-Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers Focus on the Lower Face
- BT0311-Local Injection into Mimetic Muscles of Botulinum Toxin A for the Treatment of Facial Lines
- BT0310-Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers Focus on the Upper Face
- BT0309-Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers Focus on the Midface
- BT0308-Electrophysiologic Change and Facial Contour following Botulinum Toxin A Injection in Square Faces
- BT0305-Update on botulinum toxin use in facial plastic and head and neck surgery
- BT0301-Patient Perceived Benefit in Facial Aesthetic Procedures
- BT0299-Systematic review of botulinum toxin treatment for oromandibular
- BT0297-Botulinum Toxin Type A for the Treatment of Hyperkinetic Lines of the Face
- BT0290-Lower Facial Contouring With Botulinum Toxin Type A
- BT0284-AAN updates guidelines on the uses of botulinum neurotoxin
- BT0279-Patient Perceived Benefit in Facial Aesthetic
- BT0277-Tailored botulinum toxin type A injections in aesthetic medicine consensus panel recommendations for treating the forehead based on individual facial anatomy and muscle tone
- BT0276-The Effect of Botulinum Toxin Type A on Expression Profiling of Long Noncoding RNAs in Human Dermal Fibroblasts
- BT0275-Repeated injections of botulinum toxin into the masseter muscle induce bony changes in human adults A longitudinal study
- BT0274-OnabotulinumtoxinA (Botox) in the Treatment of Crow’s Feet
- BT0269-Analysis of effectiveness and complications of botulinum toxin A masseter
- BT0236-Effect of the refrigerator storage time on the potency of botox for human extensor digitorum brevis muscle paralysis.
- BT0235-Long-Term Effects of OnabotulinumtoxinA on Facial Lines： A 19-Year Experience of Identical Twins
- BT0229-Ten Mistakes To Avoid When Injecting Botulinum Toxin
- BT0214-Safety aspects of incobotulinumtoxinA high-dose therapy.
- BT0211-Comparison of clinical marking and ultrasound-guided injection of Botulinum type A toxin into the masseter muscles for treating bruxism and its cosmetic effects
- BT0208-Injecting botulinum toxin at different depths is not effective for the correction of eyebrow asymmetry.
- BT0192-Recommendations and current practices for the reconstitution and storage of botulinum toxin type A.
- BT0189-Alteration of Skin Mechanical Properties in Patients Undergoing Botulinum Toxin Type a Injections of Forehead Rhytides
- BT0174-Botulinum toxin type A in pregnancy.
- BT0170-Considerations on patient-related outcomes with the use of botulinum toxins- is switching products safe？
- BT0169-Comparison of the Efficacy of OnabotulinumtoxinA and AbobotulinumtoxinA at the 1： 3 Conversion Ratio for the Treatment of Asymmetry....
- BT0160-Global Aesthetics Consensus- Botulinum Toxin Type A—Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use...
- BT0144-Efficacy of botulinum toxin A for treatment of unilateral spasms of the eyelid and its prognosis
- BT0142-The effects of electrical stimulation exercise on muscles injected
- BT0133-Histological changes and changes in the myosin mRNA content of the porcine masticatory muscles after masseter treatment with botulinum toxin A
- BT0124-Comparison of microneedle fractional radiofrequency therapy with intradermal botulinum toxin a injection for periorbital rejuvenation.
- BT0100-The Effect of Chemodenervation by Botulinum Neurotoxin on the Degradation of Hyaluronic Acid Fillers- An Experimental Study
- BT0099-Bilateral hypertrophy of masseteric and temporalis muscles, our fifteen patients and review of literature
- BT0092-Lifting laughter lines
- BT0064-A cross-sectional structured survey of patients receiving botulinum toxin type A treatment for blepharospasm
- BT0062-An Evaluation of Use of Botulinum Toxin Type A in the Management of Dynamic Forehead Wrinkles - A Clinical Stud
- BT0059-The Efficacy and Safety of Fractional CO2 Laser Combined with Topical Type A Botulinum Toxin for Facial Rejuvenation..
- BT0057-[Botulinum Toxin Type A and the Prevention of Hypertrophic Scars on the Maxillofacial Area and Neck- A Meta-Analysis of Randomized Controlled Trials
- BT0055-The efficacy of intradermal injection of type A botulinum toxin for facial rejuvenation
- BT0053-Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy
- BT0050-Botulinum Toxin Injection for Facial Wrinkles
- BT0043-Correlation of Botulinum Toxin Dose with Neurophysiological Parameters of Efficacy and Safety in the Glabellar Muscles...
- BT0040-Botulinum Toxin for the Treatment of Excessive Gingival Display A Systematic Review
- BT0037-The Practical Use of AbobotulinumtoxinA in Aesthetics
- BT0035-A Single-blind, Split-face, Randomized
- BT0032-Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics Onset and Duration
- BT0029-Specific aspects of a combined approach to male face correction botulinum toxin A and volumetric fillers...
- BT0028-Achieving Ideal Lower Face Aesthetic...
- BT0027Clinical Assessment of the Safety and Effectiveness of Nonablative Fractional Laser Combined with...
- BT0025-Repeated OnabotulinumtoxinA Treatment of Glabellar Lines at Rest Over Three Treatment Cycles
- BT0023-Are combined same-day treatments the future for photorejuvenation
- BT0021-Botulinum toxin to improve lower facial symmetry in facial nerve palsy
- BT0018-Patient Perceived Benefitin Facial Aesthetic ProceduresFACE-QasaTooltoStudy Botulinum ToxinInjection Outcomes
- BT0017-A Simplified Method for Smile Enhancement-Botulinum Toxin Injection for Gummy Smile
- BT0014-Characterizing the Lateral Border of the Frontalis for Safe and Effective Injection of Botulinum Toxin
- BT0012-A Simplified Approach to Botulinum Toxin Injection for the Lower Face...
- BT0011-Botulinum toxin treatment for facial palsy
- BT0010-S100 and p65 expression are increased in the masseter muscle after botulinum toxin-A injection
- BT0009-Negative effects of submandibular botulinum neurotoxin A injections on oral motor function in children...
- BT0007-Global Aesthetics Consensus Hyaluronic Acid Fillers and....
- BT0002-Aesthetic Applications of Botulinum Toxin A in Asians An International, Multidisciplinary, Pan-Asian Consensus
暂无笔记
